Connect with us

Insights

Most liver cancer could be prevented through lifestyle changes and vaccination – study

Published

on

Three in five liver cancer cases could be avoided through better hepatitis vaccination, reduced alcohol intake and efforts to tackle obesity, new research has found.

Without intervention, deaths from liver cancer are projected to rise from 760,000 in 2022 to 1.37m by 2050. The findings suggest 9m to 17m cases and 8m to 15m deaths could be prevented with targeted action.

The Lancet Commission on liver cancer found that reducing alcohol consumption, viral hepatitis B and C infections, and fatty liver disease could stop the majority of future cases.

Fatty liver disease occurs when excess fat builds up in the liver, which can lead to inflammation, liver damage and cancer.

Prof Jian Zhou of Fudan University in China, who led the research, said: “Liver cancer is a growing health issue around the world. It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5 per cent to 30 per cent.

“We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend.”

Liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer death.

The number of new cases is expected to nearly double from 870,000 in 2022 to 1.52m in 2050, largely due to population growth and ageing, with the steepest increases expected in Africa.

More than 40 per cent of global cases currently occur in China, which has high rates of hepatitis B infection.

One of the fastest growing causes is fatty liver disease, now referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), which is linked to obesity.

About one-third of the global population is thought to have MASLD, which may be prevented by eating a balanced diet, staying active and maintaining a healthy weight.

Only 20 to 30 per cent of people with MASLD go on to develop the more severe form, metabolic dysfunction-associated steatohepatitis (MASH), which can lead to liver cancer.

The commission said MASH-linked cases are projected to increase from 8 per cent of liver cancer cases in 2022 to 11 per cent in 2050.

Alcohol is the second fastest growing cause, with alcohol-related liver cancer cases expected to rise from 19 per cent to 21 per cent by 2050

In contrast, hepatitis B-related cases are projected to fall from 39 per cent to 37 per cent, while hepatitis C-related cases are expected to decline from 29 per cent to 26 per cent.

Prof Hashem B El-Serag of Baylor College of Medicine in the US said: “Liver cancer was once thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease.

“However, today, rising rates of obesity are an increasing risk factor for liver cancer, primarily due to the increase in cases of excess fat around the liver.”

The commission recommended that governments expand HBV vaccination, implement universal screening for adults, introduce minimum alcohol pricing and sugar taxes, add warning labels to unhealthy products, invest in early detection of liver damage and cancer, and improve palliative care services.

Dr Matt Hoare, associate professor in hepatology at the University of Cambridge’s Early Cancer Institute, said liver cancer was “unlike many other cancers” in that its death rate is still rising.

He noted that causes vary by region, and said Japan had successfully reduced its death rate by introducing preventive measures and improving early detection.

His team is now working to identify which liver disease patients are most likely to develop cancer using DNA sequencing of the liver.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

The Agetech World research roundup

Published

on

Super-ageing key, Seaweed’s special, hair-raising breakthrough and more

The secret of how ‘super-agers’ have the mental agility of people decades younger is centred around brain health, say US researchers.

Some elderly people are able to regenerate brain cells twice as quickly as other, healthy adults, of the same age.

While it has recently been established that we continue creating brain cells throughout our lives, the new research suggests that some people age without any signs of cognitive decline because their bodies are much better at renewing brain cells.

This is known as neurogenesis and happens in the hippocampus – which is crucial for memory.

“Super agers had twice the neurogenesis of the other healthy older adults,” said Professor Orly Lazarov, of the University of Illinois at Chicago.

“Something in their brains enables them to maintain a superior memory. I believe hippocampal neurogenesis is the secret ingredient, and the data support that.

Amino acid alert

“This is a big step forward in understanding how the human brain processes cognition, forms memories and ages.”

A super-ager is someone aged 80 or older who exhibits cognitive function that is comparable to an average person who is middle-aged.

A study of more than 270,000 participants from the UK Biobank has uncovered a link between a common amino acid and how long men live. 

Researchers found that higher levels of tyrosine – an amino acid found in protein-rich foods and often marketed as a focus-boosting supplement – were associated with shorter life expectancy in men.

The study published in Aging-US, from the University of Hong Kong and the University of Georgia, examined the role of phenylalanine and tyrosine in longevity.

Their findings suggest that higher tyrosine levels are associated with shorter life expectancy in men, raising the possibility that longevity strategies may need to differ by sex.

‘Seaing’ into the future

Researchers are using a unique Australian seaweed that mimics the biological functions of human skin to develop sustainable, regenerative wound-healing, anti-ageing solutions for complex skin injuries and burns.

The healing power of seaweed is not a new discovery.

There is evidence that it was chewed medicinally in what is now Chile more than 14,000 years ago, and that seaweed has been a versatile resource for Indigenous Australians for millennia. 

It is now believed there are some 12,000 species of seaweed around the world, and that current scientific understanding of the possible benefits of those species is just scratching the surface.

Over the last decade, University of Wollongong researchers at the Intelligent Polymer Research Institute (IPRI) have been investigating a unique Australian green seaweed with antibacterial, anti-inflammatory and regenerative properties. 

The team believes this discovery could revolutionise complex wound healing and boost longevity.

Link between obesity and muscle loss

Researchers at the UK’s University of Birmingham have identified a new mechanism by which obesity may contribute to muscle loss in older adults.

The study, published in the Journal of Cachexia, Sarcopenia and Muscle and delivered through the National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre (BRC) shows for the first time that extracellular vesicles – tiny particles released by fat tissue – can directly trigger muscle atrophy in human cells.

Sarcopenic obesity, where excess body fat coexists with reduced muscle mass and strength, is an increasingly common condition in ageing populations and is associated with frailty, reduced mobility, and poorer overall health outcomes. 

It is estimated to affect around 11 per cent of the population. 

In the study, researchers found that extracellular vesicles released from obese adipose tissue caused significant thinning of muscle fibres derived from older adults, whilst researchers found
that muscle cells derived from younger adults were resilient to these effects. 

Lead researcher Dr Joshua Price, first author and Postdoctoral Researcher, said: “It isn’t just having more fat tissue that matters.

“Obesity changes how fat tissue behaves and how it communicates with muscle.

“Ageing muscle is far more vulnerable to these altered signals, which helps explain why muscle loss accelerates with obesity later in life.”

Hair-raising breakthrough

Japanese regenerative health firm OrganTech has pinpointed the trio of cells required to prevent hair loss.

The Tokyo-based biotech said its researchers have defined a three-cell configuration capable of reconstructing hair follicle organ germs to sustain a hair growth cycle.

The work, published in Biochemical and Biophysical Research Communications, provides a potential blueprint for regeneration of hair follicles; which are complex, mini-organs that repeatedly manifest through growth, regression, rest and shedding cycles. 

Previous regenerative approaches have combined epithelial stem cells and dermal papilla cells to form early follicular structures.

But, working with researchers at the RIKEN Center for Biosystems Dynamics Research, OrganTech identified a third, previously uncharacterised, cell type that appears to be essential for complete regeneration. 

This mesenchymal cell was shown to play a critical role in triggering the transition from the resting to the growth phase of the hair cycle and in driving the follicle’s downward extension into surrounding tissue. 

OrganTech CEO Yoshio Shimo, said: “This work defines a foundational cellular configuration for functional hair follicle regeneration.

“Beyond hair biology, it reinforces our broader strategy of organ-level regenerative medicine, where precisely orchestrated epithelial and mesenchymal interactions enable stable and functional tissue reconstruction.”

Continue Reading

News

Low-dose lithium may slow Alzheimer’s verbal memory decline

Published

on

Low-dose lithium may slow verbal memory decline linked to Alzheimer’s disease in older adults, according to a pilot clinical trial.

The two-year trial enrolled adults aged 60 and older with mild cognitive impairment, a condition where people develop noticeable memory or thinking problems beyond what is typical for their age.

Participants were randomly assigned to receive either a low dose of lithium, a drug long used to treat bipolar disorder, or a placebo.

Over the study period, those receiving lithium showed a slower decline on a sensitive test of verbal memory, the ability to remember and recall words and sentences, which often worsens early in Alzheimer’s disease.

The research was led by Dr Ariel Gildengers, professor of psychiatry at the University of Pittsburgh and a geriatric psychiatrist whose previous work has suggested long-term lithium use in older adults with bipolar disorder is linked with better brain integrity.

“In a prior study, we observed that older adults with bipolar disorder who take lithium long-term tend to show markers of better brain integrity,” Gildengers said.

“The new question was whether those apparent neuroprotective effects might extend beyond mood disorders, and whether we could test that rigorously in a prospective clinical trial.”

Brain imaging showed that the hippocampus, a region of the brain important for memory, shrank over time in both groups.

Although the overall difference between groups did not reach statistical significance, further analysis suggested stronger protective effects among participants who tested positive for amyloid beta, a protein widely considered one of the key biological indicators of Alzheimer’s disease.

The study also found that low-dose lithium was safe and well tolerated in older adults when carefully monitored.

“The key point is that lithium doesn’t restore lost memory,” Gildengers said.

“What it appears to do, if the signal holds up, is slow deterioration. That distinction matters enormously when you’re designing trials and interpreting results.”

However, the trial had limitations. When it began nearly a decade ago, blood-based tests for Alzheimer’s disease were not yet available, meaning participants were enrolled based on clinical symptoms alone.

Only a subset were later found to have amyloid, which may have reduced the study’s ability to detect stronger effects.

“If we were designing this study today, we would enrol participants based on amyloid status from the start,” Gildengers said.

“That’s exactly what we’re planning for next.”

The research team is now seeking support for a larger trial that would use blood-based biomarkers, measurable biological indicators in the blood, to identify individuals most likely to benefit.

“This study tells us that the approach is feasible, safe and worth pursuing,” Gildengers said.

“But it also reminds us why careful, adequately powered trials are essential, especially when the stakes are this high.”

Continue Reading

News

Listening to music may lower dementia risk, study suggests

Published

on

Listening to or playing music regularly may lower dementia risk in adults over 70, according to research tracking more than 10,800 people.

A study of more than 10,800 adults aged over 70 found those who listened to music most days had a 39 per cent lower likelihood of developing dementia than people who sometimes, rarely or never listened.

Frequent listeners also showed a 17 per cent lower rate of cognitive impairment, meaning a noticeable decline in thinking ability that is greater than normal ageing but not severe enough to be dementia.

Participants who listened to music regularly also recorded higher overall cognitive scores and stronger episodic memory, the ability to recall specific personal experiences or everyday events.

Playing an instrument, including singing, was linked with a 35 per cent reduction in dementia risk.

People who both listened to and played music regularly had a 33 per cent lower risk of dementia and a 22 per cent lower risk of cognitive impairment.

The research was carried out by a team at Monash University in Australia.

“We know that listening to music engages multiple brain areas at once, acting like a full-brain workout,” said Emma Jaffa, a biomedical science honours student at Monash who co-authored the study with Joanne Ryan, a professor of biological neuropsychiatry at the university.

“Previous studies show it improves processing speed, language, memory and coordination. Plus, it often involves socialising with others, which helps protect brain health.”

Jaffa, who plays bass and sings, said the findings were also personally meaningful.

“I think that’s what drew me to this topic. It was the combination of a hobby and the possibility of delivering actionable insights to others,” she said.

She said she is often asked whether some types of music may offer more benefit than others.

Participants in the study were not asked which genres they listened to, but Jaffa said this is something she hopes to explore in future research.

Another question is whether listening to music might help reduce the risk of cognitive decline in people younger than 70.

Continue Reading

Trending

Agetech World